Ha Tay Pharmaceutical JSC (HNX:DHT)

Ha Tay Pharmaceutical JSC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	157,117	90,270	301,790	93,132	59,669	60,494
Short-Term Investments	70,000	90,000	80,000	53,000	350,000	-
Cash & Short-Term Investments	227,117	180,270	381,790	146,132	409,669	60,494
Cash Growth	2.07%	-52.78%	161.26%	-64.33%	577.20%	10.51%
Accounts Receivable	121,233	125,685	89,463	109,915	121,112	249,858
Other Receivables	7,481	7,927	8,412	8,964	32,917	21,800
Receivables	128,714	133,612	97,875	118,879	154,029	271,658
Inventory	551,619	527,935	378,908	460,629	339,706	373,510
Other Current Assets	75,551	83,045	150,099	285,297	103,882	27,728
Total Current Assets	983,001	924,861	1,008,673	1,010,937	1,007,287	733,390
Property, Plant & Equipment	995,208	976,101	791,736	442,074	212,752	166,103
Long-Term Investments	19,526	19,336	33,969	11,144	9,486	8,002
Other Intangible Assets	1,377	1,377	1,377	1,593	1,810	2,027
Other Long-Term Assets	4,372	4,631	2,510	3,754	6,256	10,525
Total Assets	2,003,483	1,926,305	1,838,264	1,469,502	1,237,591	920,046
Accounts Payable	305,476	235,207	146,324	196,455	113,994	260,362
Accrued Expenses	21,398	20,668	12,204	16,251	14,674	12,668
Short-Term Debt	325,692	373,274	333,483	234,630	289,429	204,182
Current Income Taxes Payable	3,302	6,057	4,958	8,758	6,288	4,598
Current Unearned Revenue	1,497	909.3	1,008	785.26	551.02	553.13
Other Current Liabilities	151,829	131,637	98,012	106,263	54,143	83,097
Total Current Liabilities	809,195	767,752	595,988	563,143	479,079	565,460
Long-Term Debt	96,913	96,913	170,218	102,213	-	-
Other Long-Term Liabilities	4,844	4,880	4,908	5,306	5,167	4,973
Total Liabilities	910,951	869,545	771,114	670,662	484,245	570,433
Common Stock	823,418	823,418	823,418	264,088	264,088	211,274
Additional Paid-In Capital	97,320	97,320	97,320	315,934	315,934	1,000
Retained Earnings	124,234	90,280	99,006	81,831	79,048	82,134
Treasury Stock	-8,084	-8,084	-8,084	-8,084	-8,084	-8,084
Comprehensive Income & Other	26,612	26,612	26,612	119,572	78,779	39,903
Total Common Equity	1,063,500	1,029,546	1,038,273	773,341	729,766	326,227
Minority Interest	29,031	27,214	28,877	25,499	23,580	23,386
Shareholders' Equity	1,092,531	1,056,760	1,067,150	798,841	753,345	349,613
Total Liabilities & Equity	2,003,483	1,926,305	1,838,264	1,469,502	1,237,591	920,046
Total Debt	422,605	470,187	503,700	336,844	289,429	204,182
Net Cash (Debt)	-195,488	-289,917	-121,910	-190,711	120,240	-143,688
Net Cash Per Share	-2374.15	-3520.97	-2410.79	-	-	-
Filing Date Shares Outstanding	82.34	82.34	50.57	-	-	-
Total Common Shares Outstanding	82.34	82.34	50.57	-	-	-
Working Capital	173,806	157,109	412,684	447,795	528,208	167,930
Book Value Per Share	12915.92	12503.56	20532.04	-	-	-
Tangible Book Value	1,062,124	1,028,170	1,036,896	771,748	727,956	324,201
Tangible Book Value Per Share	12899.20	12486.84	20504.82	-	-	-
Buildings	168,480	165,434	150,724	-	-	-
Machinery	274,821	272,572	234,134	-	-	-
Construction In Progress	812,700	790,110	638,852	301,451	64,931	63,328

Source: S&P Global Market Intelligence. Standard template. Financial Sources.